Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 34275857!ä!34275857 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pak+J+Pharm+Sci 2021 ; 34 (1(Supplementary)): 321-325 Nephropedia Template TP {{tp|p=34275857|t=2021. Less disease severity of COVID-19 among smokers: An indication of investigating nicotine as preventive measure |pdf=|usr=}}{{34275857}} gab.com Text Less disease severity of COVID-19 among smokers: An indication of investigating nicotine as preventive measure JO: Pak J Pharm Sci http://www.kidney.de/pget.php?&tw=1&pmid=34275857 #FOAvip The study was aimed to mention the epidemiology of smoking in Pakistani COVID-19 infected patients along with the disease severity, oxygen dependency and fatality rate. A cross sectional epidemiological study was carried out on 555 confirmed cases of COVID-19 infection. The median age was 47+/-16 years. 59% were male and 41% were female. Most of the patients (97.5%) survived, while only 2.5% expired. 25.6% patients required the oxygen. Total 17 (3%) COVID-19 patients with age 20-75 years were identified as smokers. No mortality was observed in smokers. The 1.4% smokers presented with mild disease, 1.2% with moderate disease and 0.4% had severe disease. According to Chi-Square test, there existed an insignificant difference (p-value: 0.38649) between smokers and non-smokers in disease severity levels. Smoking is a precursor for countless diseases, but it behaved differently in COVID-19 infected patients, as its prevalence was significantly low. We found no significant variation of the disease severity among the smokers and non-smokers. Profound experiments should be conducted to recommend whether nicotine can be used as a protective agent to negate COVID-19 infection. Twit Text FOAVip Less disease severity of COVID-19 among smokers: An indication of investigating nicotine as preventive measure ????Pak J Pharm Sci http://www.kidney.de/pget.php?&tw=1&pmid=34275857 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34275857 #FOAvip English Wikipedia <ref>{{Cite pmid|34275857}}</ref> Less disease severity of COVID-19 among smokers: An indication of investigating nicotine as preventive measure #MMPMID34275857 Ghayyur A; Hussain SS; Salam E; Saeed S; Shahid S; Salaam TU Pak J Pharm Sci 2021[Jan]; 34 (1(Supplementary)): 321-325 PMID34275857show ga The study was aimed to mention the epidemiology of smoking in Pakistani COVID-19 infected patients along with the disease severity, oxygen dependency and fatality rate. A cross sectional epidemiological study was carried out on 555 confirmed cases of COVID-19 infection. The median age was 47+/-16 years. 59% were male and 41% were female. Most of the patients (97.5%) survived, while only 2.5% expired. 25.6% patients required the oxygen. Total 17 (3%) COVID-19 patients with age 20-75 years were identified as smokers. No mortality was observed in smokers. The 1.4% smokers presented with mild disease, 1.2% with moderate disease and 0.4% had severe disease. According to Chi-Square test, there existed an insignificant difference (p-value: 0.38649) between smokers and non-smokers in disease severity levels. Smoking is a precursor for countless diseases, but it behaved differently in COVID-19 infected patients, as its prevalence was significantly low. We found no significant variation of the disease severity among the smokers and non-smokers. Profound experiments should be conducted to recommend whether nicotine can be used as a protective agent to negate COVID-19 infection. |Adolescent[MESH] |Adult[MESH] |Age Distribution[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*epidemiology/*etiology[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pakistan/epidemiology[MESH] |Severity of Illness Index[MESH] |Sex Distribution[MESH] |Smoking/*epidemiology[MESH] |Tobacco Smoking/epidemiology[MESH]Less disease severity of COVID-19 among smokers: An indication of inve(epmc).pdf DeepDyve Pubget Overpricing